Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-03-20

AUTHORS

Amandine Pallardy, Caroline Bodet-Milin, Aurore Oudoux, Loïc Campion, Emmanuelle Bourbouloux, Christine Sagan, Catherine Ansquer, Aude Testard, Isabelle Resche, Boumédiène Bridji, Françoise Kraeber-Bodéré, Caroline Rousseau

ABSTRACT

PurposeThe aim of this retrospective study was to evaluate the contribution of 18F-FDG PET to the clinical management and survival outcome of patients suspected of recurrent cervical carcinoma and in line with the hypothesis that early diagnosis of recurrent cervical cancer may improve overall survival.MethodsA total of 40 patients underwent conventional imaging (CI) and FDG PET/CT for suspected cervical cancer. Clinical management decisions were recorded with CI and additional PET/CT. Discordances and concordances between CI and PET/CT results were compared to the final diagnosis as based on histopathology analysis or follow-up considered as the gold standard.ResultsThe final diagnosis was established pathologically (n = 25) or by median clinical follow-up for 48 months after the PET (n = 15). The PET/CT was positive in 76% (20/26) of patients compared to 19% (6/26) with CI. Globally PET/CT modified the treatment plan in 55% (22/40) of patients and in 75% (18/24) when the CI was negative prior to PET/CT. These changes led to the use of previously unplanned therapeutic procedures in 37.5% (15/40). When FDG PET was positive for recurrence (> 3 foci), the median overall survival was 12 months (2–70) compared to patients with PET findings with ≤ 1 focus for which the median survival was not attained (p = 0.007). A multivariate analysis of prognostic factors demonstrated that abnormal FDG uptake (> 3 foci) was the most significant factor (p < 0.03) for death from cervical cancer.ConclusionFDG PET is a valuable tool in the case of suspected recurrence of cervical cancer on account of its impact on treatment planning and especially in predicting patient outcome. More... »

PAGES

1270-1278

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-010-1417-1

DOI

http://dx.doi.org/10.1007/s00259-010-1417-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020139561

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20306032


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, X-Ray Computed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uterine Cervical Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Nuclear Medicine Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pallardy", 
        "givenName": "Amandine", 
        "id": "sg:person.0675243557.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675243557.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department, University Hospital, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.277151.7", 
          "name": [
            "Nuclear Medicine Department, University Hospital, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bodet-Milin", 
        "givenName": "Caroline", 
        "id": "sg:person.01212260416.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212260416.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department, University Hospital, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.277151.7", 
          "name": [
            "Nuclear Medicine Department, University Hospital, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oudoux", 
        "givenName": "Aurore", 
        "id": "sg:person.01246522327.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246522327.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Center CRCNA, INSERM UMR 892, Nantes University, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.4817.a", 
          "name": [
            "Biostatistics Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France", 
            "Cancer Research Center CRCNA, INSERM UMR 892, Nantes University, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campion", 
        "givenName": "Lo\u00efc", 
        "id": "sg:person.01100327307.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100327307.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bourbouloux", 
        "givenName": "Emmanuelle", 
        "id": "sg:person.01237674121.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237674121.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pathology Department, University Hospital, Boulevard Monod, Saint Herblain, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Pathology Department, University Hospital, Boulevard Monod, Saint Herblain, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sagan", 
        "givenName": "Christine", 
        "id": "sg:person.01010656316.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010656316.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department, University Hospital, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.277151.7", 
          "name": [
            "Nuclear Medicine Department, University Hospital, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ansquer", 
        "givenName": "Catherine", 
        "id": "sg:person.01050273323.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050273323.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Nuclear Medicine Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Testard", 
        "givenName": "Aude", 
        "id": "sg:person.01057605357.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057605357.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Nuclear Medicine Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Resche", 
        "givenName": "Isabelle", 
        "id": "sg:person.0776514743.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776514743.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Nuclear Medicine Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bridji", 
        "givenName": "Boum\u00e9di\u00e8ne", 
        "id": "sg:person.0627130357.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627130357.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Center CRCNA, INSERM UMR 892, Nantes University, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.4817.a", 
          "name": [
            "Nuclear Medicine Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France", 
            "Nuclear Medicine Department, University Hospital, Nantes, France", 
            "Cancer Research Center CRCNA, INSERM UMR 892, Nantes University, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kraeber-Bod\u00e9r\u00e9", 
        "givenName": "Fran\u00e7oise", 
        "id": "sg:person.0653324404.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653324404.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Research Center CRCNA, INSERM UMR 892, Nantes University, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.4817.a", 
          "name": [
            "Nuclear Medicine Department, Ren\u00e9 Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France", 
            "Cancer Research Center CRCNA, INSERM UMR 892, Nantes University, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rousseau", 
        "givenName": "Caroline", 
        "id": "sg:person.01240530667.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240530667.47"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-008-0890-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006526925", 
          "https://doi.org/10.1007/s00259-008-0890-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-007-0612-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003953034", 
          "https://doi.org/10.1007/s00259-007-0612-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-009-1206-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004267887", 
          "https://doi.org/10.1007/s00259-009-1206-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-006-0251-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007635461", 
          "https://doi.org/10.1007/s00259-006-0251-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-03-20", 
    "datePublishedReg": "2010-03-20", 
    "description": "PurposeThe aim of this retrospective study was to evaluate the contribution of 18F-FDG PET to the clinical management and survival outcome of patients suspected of recurrent cervical carcinoma and in line with the hypothesis that early diagnosis of recurrent cervical cancer may improve overall survival.MethodsA total of 40 patients underwent conventional imaging (CI) and FDG PET/CT for suspected cervical cancer. Clinical management decisions were recorded with CI and additional PET/CT. Discordances and concordances between CI and PET/CT results were compared to the final diagnosis as based on histopathology analysis or follow-up considered as the gold standard.ResultsThe final diagnosis was established pathologically (n\u2009=\u200925) or by median clinical follow-up for 48\u00a0months after the PET (n\u2009=\u200915). The PET/CT was positive in 76% (20/26) of patients compared to 19% (6/26) with CI. Globally PET/CT modified the treatment plan in 55% (22/40) of patients and in 75% (18/24) when the CI was negative prior to PET/CT. These changes led to the use of previously unplanned therapeutic procedures in 37.5% (15/40). When FDG PET was positive for recurrence (>\u20093 foci), the median overall survival was 12\u00a0months (2\u201370) compared to patients with PET findings with \u2264\u20091 focus for which the median survival was not attained (p\u2009=\u20090.007). A multivariate analysis of prognostic factors demonstrated that abnormal FDG uptake (>\u20093 foci) was the most significant factor (p\u2009<\u20090.03) for death from cervical cancer.ConclusionFDG PET is a valuable tool in the case of suspected recurrence of cervical cancer on account of its impact on treatment planning and especially in predicting patient outcome.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-010-1417-1", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "keywords": [
      "PET/CT", 
      "recurrent cervical carcinoma", 
      "cervical cancer", 
      "conventional imaging", 
      "overall survival", 
      "FDG-PET", 
      "cervical carcinoma", 
      "final diagnosis", 
      "PET/CT results", 
      "FDG PET/CT", 
      "additional PET/CT", 
      "unplanned therapeutic procedures", 
      "recurrent cervical cancer", 
      "median overall survival", 
      "abnormal FDG uptake", 
      "clinical management decisions", 
      "ConclusionFDG-PET", 
      "median survival", 
      "PET findings", 
      "prognostic factors", 
      "survival impact", 
      "retrospective study", 
      "survival outcomes", 
      "FDG uptake", 
      "clinical management", 
      "patient outcomes", 
      "early diagnosis", 
      "patients", 
      "therapeutic procedures", 
      "CT results", 
      "treatment plan", 
      "multivariate analysis", 
      "histopathology analysis", 
      "cancer", 
      "CT", 
      "gold standard", 
      "diagnosis", 
      "treatment planning", 
      "carcinoma", 
      "recurrence", 
      "survival", 
      "months", 
      "outcomes", 
      "PET", 
      "significant factor", 
      "suspicion", 
      "death", 
      "valuable tool", 
      "factors", 
      "total", 
      "concordance", 
      "discordance", 
      "imaging", 
      "aim", 
      "findings", 
      "uptake", 
      "management", 
      "cases", 
      "study", 
      "impact", 
      "procedure", 
      "analysis", 
      "hypothesis", 
      "management decisions", 
      "changes", 
      "use", 
      "lines", 
      "plan", 
      "standards", 
      "focus", 
      "results", 
      "tool", 
      "planning", 
      "decisions", 
      "contribution", 
      "account"
    ], 
    "name": "Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma", 
    "pagination": "1270-1278", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020139561"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-010-1417-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20306032"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-010-1417-1", 
      "https://app.dimensions.ai/details/publication/pub.1020139561"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_518.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-010-1417-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-010-1417-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-010-1417-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-010-1417-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-010-1417-1'


 

This table displays all metadata directly associated to this object as RDF triples.

299 TRIPLES      21 PREDICATES      119 URIs      106 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-010-1417-1 schema:about N03c1594d30074b988d0fbeade25ae1fe
2 N0f9993d0c1bd4685be1b78655ea1f694
3 N1248e717a0104fdab8af44a40f47f942
4 N64a6aa477f484e7593a45f6d7cd44ef5
5 N81500a00023a49ea9a4d9fe171af72a9
6 Na443d7c1ff7743beb8941ec1d9d93f07
7 Nb919986673da46a7bb8b9e0dc87d2e61
8 Nd2782a484d374b6784e30811b8020ba0
9 Nd2f388bf99a743d3827ed630b9c2a4ac
10 Nd8a8f294b97a410fb063d427d42c8153
11 Nded5ef4055e14ad58afc059f33bc0d4a
12 Ne965277af1344c5e85f72dc457ae548b
13 Nf193382e947c498ab50414d62d2dd8ce
14 anzsrc-for:11
15 anzsrc-for:1103
16 anzsrc-for:1112
17 schema:author N7a318e60e78e41279a20b61636026784
18 schema:citation sg:pub.10.1007/s00259-006-0251-y
19 sg:pub.10.1007/s00259-007-0612-1
20 sg:pub.10.1007/s00259-008-0890-2
21 sg:pub.10.1007/s00259-009-1206-x
22 schema:datePublished 2010-03-20
23 schema:datePublishedReg 2010-03-20
24 schema:description PurposeThe aim of this retrospective study was to evaluate the contribution of 18F-FDG PET to the clinical management and survival outcome of patients suspected of recurrent cervical carcinoma and in line with the hypothesis that early diagnosis of recurrent cervical cancer may improve overall survival.MethodsA total of 40 patients underwent conventional imaging (CI) and FDG PET/CT for suspected cervical cancer. Clinical management decisions were recorded with CI and additional PET/CT. Discordances and concordances between CI and PET/CT results were compared to the final diagnosis as based on histopathology analysis or follow-up considered as the gold standard.ResultsThe final diagnosis was established pathologically (n = 25) or by median clinical follow-up for 48 months after the PET (n = 15). The PET/CT was positive in 76% (20/26) of patients compared to 19% (6/26) with CI. Globally PET/CT modified the treatment plan in 55% (22/40) of patients and in 75% (18/24) when the CI was negative prior to PET/CT. These changes led to the use of previously unplanned therapeutic procedures in 37.5% (15/40). When FDG PET was positive for recurrence (> 3 foci), the median overall survival was 12 months (2–70) compared to patients with PET findings with ≤ 1 focus for which the median survival was not attained (p = 0.007). A multivariate analysis of prognostic factors demonstrated that abnormal FDG uptake (> 3 foci) was the most significant factor (p < 0.03) for death from cervical cancer.ConclusionFDG PET is a valuable tool in the case of suspected recurrence of cervical cancer on account of its impact on treatment planning and especially in predicting patient outcome.
25 schema:genre article
26 schema:isAccessibleForFree false
27 schema:isPartOf N1083e2646a854fa49da76f4c3f09919a
28 N8d045052e849418fa8e6bf48386b2387
29 sg:journal.1297401
30 schema:keywords CT
31 CT results
32 ConclusionFDG-PET
33 FDG PET/CT
34 FDG uptake
35 FDG-PET
36 PET
37 PET findings
38 PET/CT
39 PET/CT results
40 abnormal FDG uptake
41 account
42 additional PET/CT
43 aim
44 analysis
45 cancer
46 carcinoma
47 cases
48 cervical cancer
49 cervical carcinoma
50 changes
51 clinical management
52 clinical management decisions
53 concordance
54 contribution
55 conventional imaging
56 death
57 decisions
58 diagnosis
59 discordance
60 early diagnosis
61 factors
62 final diagnosis
63 findings
64 focus
65 gold standard
66 histopathology analysis
67 hypothesis
68 imaging
69 impact
70 lines
71 management
72 management decisions
73 median overall survival
74 median survival
75 months
76 multivariate analysis
77 outcomes
78 overall survival
79 patient outcomes
80 patients
81 plan
82 planning
83 procedure
84 prognostic factors
85 recurrence
86 recurrent cervical cancer
87 recurrent cervical carcinoma
88 results
89 retrospective study
90 significant factor
91 standards
92 study
93 survival
94 survival impact
95 survival outcomes
96 suspicion
97 therapeutic procedures
98 tool
99 total
100 treatment plan
101 treatment planning
102 unplanned therapeutic procedures
103 uptake
104 use
105 valuable tool
106 schema:name Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma
107 schema:pagination 1270-1278
108 schema:productId N2b7222045c234fa6b1bc5e8450144336
109 N3f378ba91b0149b599767556fe6d72c9
110 N84cd5e005d614eb09f32dc68cfb4b373
111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020139561
112 https://doi.org/10.1007/s00259-010-1417-1
113 schema:sdDatePublished 2022-12-01T06:28
114 schema:sdLicense https://scigraph.springernature.com/explorer/license/
115 schema:sdPublisher N148f5eed8aa144679b91bcda145e2a56
116 schema:url https://doi.org/10.1007/s00259-010-1417-1
117 sgo:license sg:explorer/license/
118 sgo:sdDataset articles
119 rdf:type schema:ScholarlyArticle
120 N03c1594d30074b988d0fbeade25ae1fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Aged
122 rdf:type schema:DefinedTerm
123 N0a3a442c6eec468db6c1358cd8156663 rdf:first sg:person.01050273323.41
124 rdf:rest Nf5e46aaf6d504d09b1697492d2d47590
125 N0f9993d0c1bd4685be1b78655ea1f694 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Aged, 80 and over
127 rdf:type schema:DefinedTerm
128 N1083e2646a854fa49da76f4c3f09919a schema:volumeNumber 37
129 rdf:type schema:PublicationVolume
130 N112f49f96281470eab20982e03004198 rdf:first sg:person.01212260416.00
131 rdf:rest Nf348c0f36f5c479fac2bb16fe079e9a3
132 N1248e717a0104fdab8af44a40f47f942 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Humans
134 rdf:type schema:DefinedTerm
135 N148f5eed8aa144679b91bcda145e2a56 schema:name Springer Nature - SN SciGraph project
136 rdf:type schema:Organization
137 N2b7222045c234fa6b1bc5e8450144336 schema:name pubmed_id
138 schema:value 20306032
139 rdf:type schema:PropertyValue
140 N3f378ba91b0149b599767556fe6d72c9 schema:name doi
141 schema:value 10.1007/s00259-010-1417-1
142 rdf:type schema:PropertyValue
143 N4a5f75fadaa54c4a89d4158be680edc8 rdf:first sg:person.0653324404.03
144 rdf:rest Ned8122a165d24c3abca6360163c00296
145 N56f8a1abaa4a4c9ba6c54baa44fea7c8 rdf:first sg:person.01237674121.70
146 rdf:rest N828420e6efe949de86dfd1928a1cd05f
147 N64a6aa477f484e7593a45f6d7cd44ef5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Fluorodeoxyglucose F18
149 rdf:type schema:DefinedTerm
150 N7a318e60e78e41279a20b61636026784 rdf:first sg:person.0675243557.38
151 rdf:rest N112f49f96281470eab20982e03004198
152 N7f6f78ef3c6345f3be631995c86cf56b rdf:first sg:person.0627130357.25
153 rdf:rest N4a5f75fadaa54c4a89d4158be680edc8
154 N81500a00023a49ea9a4d9fe171af72a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Retrospective Studies
156 rdf:type schema:DefinedTerm
157 N828420e6efe949de86dfd1928a1cd05f rdf:first sg:person.01010656316.57
158 rdf:rest N0a3a442c6eec468db6c1358cd8156663
159 N84cd5e005d614eb09f32dc68cfb4b373 schema:name dimensions_id
160 schema:value pub.1020139561
161 rdf:type schema:PropertyValue
162 N8d045052e849418fa8e6bf48386b2387 schema:issueNumber 7
163 rdf:type schema:PublicationIssue
164 Na443d7c1ff7743beb8941ec1d9d93f07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Female
166 rdf:type schema:DefinedTerm
167 Nb919986673da46a7bb8b9e0dc87d2e61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Uterine Cervical Neoplasms
169 rdf:type schema:DefinedTerm
170 Nd2782a484d374b6784e30811b8020ba0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Positron-Emission Tomography
172 rdf:type schema:DefinedTerm
173 Nd2f388bf99a743d3827ed630b9c2a4ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Neoplasm Recurrence, Local
175 rdf:type schema:DefinedTerm
176 Nd8a8f294b97a410fb063d427d42c8153 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Tomography, X-Ray Computed
178 rdf:type schema:DefinedTerm
179 Nded5ef4055e14ad58afc059f33bc0d4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Survival Analysis
181 rdf:type schema:DefinedTerm
182 Ne60d0cdd77624fe69f2b559d64133f36 rdf:first sg:person.0776514743.28
183 rdf:rest N7f6f78ef3c6345f3be631995c86cf56b
184 Ne965277af1344c5e85f72dc457ae548b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Middle Aged
186 rdf:type schema:DefinedTerm
187 Ned8122a165d24c3abca6360163c00296 rdf:first sg:person.01240530667.47
188 rdf:rest rdf:nil
189 Nf193382e947c498ab50414d62d2dd8ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Adult
191 rdf:type schema:DefinedTerm
192 Nf348c0f36f5c479fac2bb16fe079e9a3 rdf:first sg:person.01246522327.10
193 rdf:rest Nfb12d4d8c2964d94b1eb88fc5b04aa72
194 Nf5e46aaf6d504d09b1697492d2d47590 rdf:first sg:person.01057605357.62
195 rdf:rest Ne60d0cdd77624fe69f2b559d64133f36
196 Nfb12d4d8c2964d94b1eb88fc5b04aa72 rdf:first sg:person.01100327307.34
197 rdf:rest N56f8a1abaa4a4c9ba6c54baa44fea7c8
198 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
199 schema:name Medical and Health Sciences
200 rdf:type schema:DefinedTerm
201 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
202 schema:name Clinical Sciences
203 rdf:type schema:DefinedTerm
204 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
205 schema:name Oncology and Carcinogenesis
206 rdf:type schema:DefinedTerm
207 sg:journal.1297401 schema:issn 1619-7070
208 1619-7089
209 schema:name European Journal of Nuclear Medicine and Molecular Imaging
210 schema:publisher Springer Nature
211 rdf:type schema:Periodical
212 sg:person.01010656316.57 schema:affiliation grid-institutes:None
213 schema:familyName Sagan
214 schema:givenName Christine
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010656316.57
216 rdf:type schema:Person
217 sg:person.01050273323.41 schema:affiliation grid-institutes:grid.277151.7
218 schema:familyName Ansquer
219 schema:givenName Catherine
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050273323.41
221 rdf:type schema:Person
222 sg:person.01057605357.62 schema:affiliation grid-institutes:None
223 schema:familyName Testard
224 schema:givenName Aude
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057605357.62
226 rdf:type schema:Person
227 sg:person.01100327307.34 schema:affiliation grid-institutes:grid.4817.a
228 schema:familyName Campion
229 schema:givenName Loïc
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100327307.34
231 rdf:type schema:Person
232 sg:person.01212260416.00 schema:affiliation grid-institutes:grid.277151.7
233 schema:familyName Bodet-Milin
234 schema:givenName Caroline
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212260416.00
236 rdf:type schema:Person
237 sg:person.01237674121.70 schema:affiliation grid-institutes:None
238 schema:familyName Bourbouloux
239 schema:givenName Emmanuelle
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237674121.70
241 rdf:type schema:Person
242 sg:person.01240530667.47 schema:affiliation grid-institutes:grid.4817.a
243 schema:familyName Rousseau
244 schema:givenName Caroline
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240530667.47
246 rdf:type schema:Person
247 sg:person.01246522327.10 schema:affiliation grid-institutes:grid.277151.7
248 schema:familyName Oudoux
249 schema:givenName Aurore
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246522327.10
251 rdf:type schema:Person
252 sg:person.0627130357.25 schema:affiliation grid-institutes:None
253 schema:familyName Bridji
254 schema:givenName Boumédiène
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627130357.25
256 rdf:type schema:Person
257 sg:person.0653324404.03 schema:affiliation grid-institutes:grid.4817.a
258 schema:familyName Kraeber-Bodéré
259 schema:givenName Françoise
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653324404.03
261 rdf:type schema:Person
262 sg:person.0675243557.38 schema:affiliation grid-institutes:None
263 schema:familyName Pallardy
264 schema:givenName Amandine
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675243557.38
266 rdf:type schema:Person
267 sg:person.0776514743.28 schema:affiliation grid-institutes:None
268 schema:familyName Resche
269 schema:givenName Isabelle
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776514743.28
271 rdf:type schema:Person
272 sg:pub.10.1007/s00259-006-0251-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1007635461
273 https://doi.org/10.1007/s00259-006-0251-y
274 rdf:type schema:CreativeWork
275 sg:pub.10.1007/s00259-007-0612-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003953034
276 https://doi.org/10.1007/s00259-007-0612-1
277 rdf:type schema:CreativeWork
278 sg:pub.10.1007/s00259-008-0890-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006526925
279 https://doi.org/10.1007/s00259-008-0890-2
280 rdf:type schema:CreativeWork
281 sg:pub.10.1007/s00259-009-1206-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004267887
282 https://doi.org/10.1007/s00259-009-1206-x
283 rdf:type schema:CreativeWork
284 grid-institutes:None schema:alternateName Medical Oncology Department, René Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France
285 Nuclear Medicine Department, René Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France
286 Pathology Department, University Hospital, Boulevard Monod, Saint Herblain, France
287 schema:name Medical Oncology Department, René Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France
288 Nuclear Medicine Department, René Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France
289 Pathology Department, University Hospital, Boulevard Monod, Saint Herblain, France
290 rdf:type schema:Organization
291 grid-institutes:grid.277151.7 schema:alternateName Nuclear Medicine Department, University Hospital, Nantes, France
292 schema:name Nuclear Medicine Department, University Hospital, Nantes, France
293 rdf:type schema:Organization
294 grid-institutes:grid.4817.a schema:alternateName Cancer Research Center CRCNA, INSERM UMR 892, Nantes University, Nantes, France
295 schema:name Biostatistics Department, René Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France
296 Cancer Research Center CRCNA, INSERM UMR 892, Nantes University, Nantes, France
297 Nuclear Medicine Department, René Gauducheau Cancer Center, Boulevard Monod, Saint Herblain, France
298 Nuclear Medicine Department, University Hospital, Nantes, France
299 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...